Protagonist Therapeutics Știri Eulerpool

Protagonist Therapeutics Știri Acțiune

Protagonist Therapeutics este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente Protagonist Therapeutics știri le adunăm aici.

• 29 iunie ·

  SeekingAlpha
  Top Forensic Value Mid-Year 2025 Selections: Highest Positive And Negative Scoring Stocks For July
• 26 iunie ·

  Yahoo
  Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate
• 24 iunie ·

  Yahoo
  Protagonist Therapeutics, Takeda Pharmaceutical Announce Positive Phase 3 Rusfertide Results for Polycythemia Vera
• 20 iunie ·

  Yahoo
  Citi Rates Protagonist Therapeutics (PTGX) as Buy Protagonists Drugs Opportunity
• 20 iunie ·

  SeekingAlpha
  Protagonist Therapeutics: Two 'Slam Dunk' Sets Of Pivotal Data Set Up Bull Case
• 9 iunie ·

  SeekingAlpha
  ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
• 5 iunie ·

  Yahoo
  Exploring Three High Growth Tech Stocks In The US Market
• 1 iunie ·

  Yahoo
  Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera
• 28 mai ·

  SeekingAlpha
  Carillon Eagle Small Cap Growth Fund Q1 2025 Commentary
• 27 mai ·

  Yahoo
  Protagonist Therapeutics (PTGX) Rose on Positive Trial Outcome